Riskpilot← Back to searchSign inGet full accessAVENA AS
ASActiveOrg 920422144Presthaugvegen 1B, 5521 HaugesundOther human health activities n.e.c. · NACE 8699Est. 20181 employees
Revenue 2024
NOK 145K
+218% vs 2023
EBITDA margin
-5.7%
-119% vs 2023
Equity ratio
50.3%
Financial strength
Net profit 2024
NOK -8K
-119% vs 2023
| Revenue | NOK 145K | +218% |
| EBITDA | NOK -8K | -119% |
| Net profit | NOK -8K | -119% |
| Total assets | NOK 54K | +41% |
| Equity | NOK 27K | -23% |
| Employees | 1 | — |
Legal name
AVENA AS
Org number
920422144
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
12. februar 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene eller styrets leder alene.
Company purpose
Tilby salg av helsetjenester i form av ernæringsbehandling samt alt som hører til dette.
Address
Presthaugvegen 1B, 5521 Haugesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 175 | 99 | 53 | 53 | 51 | 46 | 145 |
| Staff expenses | −48 | −97 | −32 | −34 | −34 | −26 | −134 |
| EBITDA | 69 | −59 | 7 | 7 | 0 | −4 | −8 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 69 | −59 | 7 | 7 | 0 | −4 | −8 |
| Net financials | 0 | 0 | 0 | 0 | −0 | 0 | 0 |
| Profit before tax | 69 | −59 | 7 | 7 | −0 | −4 | −8 |
| Tax | 16 | −1 | −6 | −0 | −0 | −0 | −0 |
| Net profit | 53 | −58 | 12 | 7 | −0 | −4 | −8 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 110 | 35 | 40 | 47 | 43 | 39 | 54 |
| Equity | 78 | 20 | 33 | 40 | 40 | 36 | 27 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 32 | 15 | 7 | 8 | 4 | 3 | 27 |
| Total debt | 32 | 15 | 7 | 8 | 4 | 3 | 27 |
EBITDA margin
-5.7%
This company
15.8%
Market median
-136% vs market
20182024
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20182024
Return on equity
-30.2%
This company
18.4%
Market median
-264% vs market
20182024
Net profit margin
-5.7%
This company
8.1%
Market median
-170% vs market
20182024
Asset turnover
2.67×
This company
1.12×
Market median
+138% vs market
20182024
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20182024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-24 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AS Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AVENA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Sætre | Chief Executive Officer | 0 companies |
| Caroline Jensen | Chairman | 0 companies |
| Marit Sætre Færevåg | Board of Directors | 0 companies |